DAPAFLOZIN TG 10/20

Dapaflozin TG 10/20 is a powerful triple-action oral medication combining:

• Dapagliflozin 10 mg – An SGLT2 inhibitor that reduces blood glucose by promoting urinary glucose excretion.

• Teneligliptin 20 mg – A DPP-4 inhibitor that increases insulin secretion and decreases glucagon levels.

This unique combination is specially designed for patients with Type 2 Diabetes Mellitus who need stronger control of their blood sugar levels through dual antidiabetic mechanisms.

Key Benefits:

• Dual glucose-lowering pathways for improved glycemic control

• Helps reduce HbA1c more effectively than monotherapy

• Low risk of hypoglycemia

• May support weight loss and cardiovascular health

• Convenient once-daily oral tablet